n-acetylmannosamine has been researched along with Diabetic Glomerulosclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gao, Y; Jiang, H; Ma, Y; Xie, D | 1 |
Chen, H; Guo, K; Lu, J; Ma, Y; Pan, P; Wu, M | 1 |
2 other study(ies) available for n-acetylmannosamine and Diabetic Glomerulosclerosis
Article | Year |
---|---|
ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Female; Hexosamines; Humans; Kidney; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleotides; Podocytes; Pyroptosis; Reactive Oxygen Species; Signal Transduction; Streptozocin | 2022 |
Hyposialylated angiopoietin-like-4 induces apoptosis of podocytes via β1 Integrin/FAK signaling in diabetic nephropathy.
Topics: Actin Cytoskeleton; Angiopoietin-Like Protein 4; Animals; Apoptosis; Cell Line; Cell Line, Transformed; Diabetic Nephropathies; Focal Adhesion Protein-Tyrosine Kinases; Glucose; Hexosamines; Humans; Hyperglycemia; Integrin beta1; Male; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Podocytes; Rats, Sprague-Dawley; Signal Transduction; Up-Regulation | 2020 |